Newswise News from Cell Proliferation Latest news from Cell Proliferation on Newswise en-us Copyright 2024 Newswise Newswise News from Cell Proliferation 115 31 / /images/newswise-logo-rss.gif Manufacturing clinical‐grade human induced pluripotent stem cell‐derived beta cells for diabetes treatment /articles/manufacturing-clinical-grade-human-induced-pluripotent-nbsp-stem-cell-derived-beta-cells-for-diabetes-treatment/?sc=rsin /articles/manufacturing-clinical-grade-human-induced-pluripotent-nbsp-stem-cell-derived-beta-cells-for-diabetes-treatment/?sc=rsin Fri, 29 Apr 2022 05:00:00 EST ... This review focuses on the key processes and guidelines for clinical translation of human induced pluripotent stem cell (hiPSC)derived β cells for diabetes cell therapy. Here, we discuss the (1) key considerations of manufacturing clinical-grade hiPSCs ... Cell Proliferation